The efficacy of simvastatin is not influenced by CYP2D6 polymorphism

Clin Pharmacol Ther. 2002 Nov;72(5):595-6.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Alleles
  • Anticholesteremic Agents / adverse effects
  • Anticholesteremic Agents / therapeutic use*
  • Cytochrome P-450 CYP2D6 / genetics*
  • Humans
  • Hypercholesterolemia / drug therapy*
  • Hypercholesterolemia / enzymology
  • Hypercholesterolemia / genetics*
  • Polymorphism, Genetic / genetics*
  • Simvastatin / adverse effects
  • Simvastatin / therapeutic use*

Substances

  • Anticholesteremic Agents
  • Simvastatin
  • Cytochrome P-450 CYP2D6